New malaria treatment plan put to the test in peru
NCT ID NCT05361486
First seen Mar 10, 2026 · Last updated May 08, 2026 · Updated 7 times
Summary
This study looked at whether healthcare providers in Peru could successfully follow a new treatment plan for vivax malaria. The plan included a test for a enzyme called G6PD and two medicines, tafenoquine or primaquine. 187 patients took part, and the goal was to see how well providers stuck to the new plan.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA VIVAX are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nauta Nucleo- Base
Nauta, Loreto, 16310, Peru
Conditions
Explore the condition pages connected to this study.